Sodium-dependent glucose transporter 2 inhibition and the atrial antiremodelling effects in HFrEF patients

School of Medicine, Università del Piemonte Orientale, Novara, Istituto Iperbarico, Villafranca, Verona, Italy

Correspondence to Prof. Paolo N. Marino, EFESC, FACC, Istituto Iperbarico, Villafranca, Verona, Italy E-mail: [email protected]

Received 19 July, 2023